DCF — UT HEALTH EAST TEXAS TYLER
Enterprise Value: $-412.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-412.7M
Enterprise Value
$-138.1M
PV of Cash Flows
$-274.7M
PV of Terminal Value
$-442.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $480.7M | $-21.6M | -4.0% | $-42.0M | $-38.2M |
| Year 2 | $495.1M | $-17.3M | -3.0% | $-38.3M | $-31.6M |
| Year 3 | $510.0M | $-12.7M | -2.0% | $-34.3M | $-25.8M |
| Year 4 | $525.3M | $-10.5M | -2.0% | $-32.7M | $-22.4M |
| Year 5 | $541.0M | $-9.5M | -2.0% | $-32.4M | $-20.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-412.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$466.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999999935717148
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5